Market Overview:
The global pharmaceutical polyacrylic resin market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for tablet, pill, and granules from the pharmaceutical industry. In addition, the growing population and rising income levels are also contributing to the growth of this market. Based on type, polyacrylic resin III is expected to account for the largest share of the global pharmaceutical polyacrylic resin market in 2018. This segment is projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030 due to its superior properties such as clarity, toughness, and resistance against chemicals and solvents. Based on application, tablet is expected to account for the largest share ofthe global pharmaceutical polyacrylic resin market in 2018.
Product Definition:
A pharmaceutical polyacrylic resin is a synthetic resin that is used in the manufacture of drugs and other pharmaceutical products. It is an important component of many tablets, capsules, and other solid dosage forms.
Polyacrylic resin III:
Polyacrylic resin III is a water-soluble polymer with high viscosity. It has applications in pharmaceuticals and personal care industries owing to its ability to adjust the pH value of formulations. It also helps in maintaining the viscosity of solutions, thus making it suitable for ointments and gels formulation development.
Increasing demand for biodegradable polymers due to growing environmental concerns is expected to drive market growth over the forecast period.
Polyacrylic resin II:
Polyacrylic resin II is a water-soluble polymer with high viscosity. It has applications in pharmaceuticals and nutraceuticals industries. Polyacrylic resins are used as excipients in the production of tablets, capsules, syrups, solutions and emulsions for oral use.
Application Insights:
Based on application, the global pharmaceutical polyacrylic resin market is segmented into tablet, pill, granules and others. Tablet emerged as the largest segment in 2017 and is expected to maintain its lead over the forecast period. The growing use of tablets for oral administration in medical procedures such as chemotherapy or anesthesia is one of the key factors driving this growth. Moreover, increasing focus on providing patient-specific drug formulations by way of microparticles or nanoparticles embedded with drugs for targeted delivery systems will further boost product demand in tablets applications during the forecast period.
The pill application segment accounted for a significant share owing to their high specificity regarding target organs and tissues along with low rate of systemic absorption compared to other forms such as suspension liquid or powder which are used for parenteral injection purposes.
Regional Analysis:
Asia Pacific is expected to be the fastest growing regional market with a CAGR of XX% from 2018 to 2030 owing to increasing healthcare spending in emerging countries such as China and India. Moreover, rising prevalence of chronic diseases such as cardiovascular disorders, cancer, diabetes among others will drive the demand for pharmaceutical products over the forecast period. Increasing geriatric population and awareness about healthy living are also driving this market in Asia Pacific region.
In addition, favorable government policies regarding R&D activities are anticipated to fuel growth over the forecast period in Asia Pacific region which will lead to an increase in product consumption by companies for drug manufacturing purposes leading to industry expansion across this region during the forecast period.
Growth Factors:
- Increasing demand for polyacrylic resin in the pharmaceutical industry due to its properties such as clarity, chemical resistance, and heat resistance.
- Rising demand for polyacrylic resin from emerging markets such as China and India due to the growth of the pharmaceutical industry in these countries.
- Growing use of polyacrylic resin in drug delivery systems and medical devices owing to its biocompatibility and non-toxicity properties.
- Increasing research on new applications of polyacrylic resin in the pharmaceutical sector which is expected to open up new market opportunities for this product over the next few years. 5) Technological advancements that are taking place in the production process of polyacrylic resins which is resulting in better quality products with improved performance characteristics
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Polyacrylic resin Market Research Report
By Type
Polyacrylic resin III, Polyacrylic resin II, Polyacrylic resin IV, Others
By Application
Tablet, Pill, Granules, Other
By Companies
Huzhou Zhanwang Pharmaceutical, Xi'an Yuelai Yiyao, Anhui Shanhe Pharmaceutical Excipients, Yuekang Yaoye Anhui Tianran Zhiyao, Lianyungang Wantai Pharmaceutical Material, Xi'an Tianzheng Medical Materials Co.,Ltd, Evonik, Huzhou Zhanwang Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
158
Number of Tables & Figures
111
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Polyacrylic resin Market Report Segments:
The global Pharmaceutical Polyacrylic resin market is segmented on the basis of:
Types
Polyacrylic resin III, Polyacrylic resin II, Polyacrylic resin IV, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tablet, Pill, Granules, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Huzhou Zhanwang Pharmaceutical
- Xi'an Yuelai Yiyao
- Anhui Shanhe Pharmaceutical Excipients
- Yuekang Yaoye Anhui Tianran Zhiyao
- Lianyungang Wantai Pharmaceutical Material
- Xi'an Tianzheng Medical Materials Co.,Ltd
- Evonik
- Huzhou Zhanwang Pharmaceutical
Highlights of The Pharmaceutical Polyacrylic resin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polyacrylic resin III
- Polyacrylic resin II
- Polyacrylic resin IV
- Others
- By Application:
- Tablet
- Pill
- Granules
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Polyacrylic resin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Polyacrylic resin is a type of plastic that is made from two or more types of acrylonitrile butadiene styrene (ABS) resins. It has a high resistance to heat, chemicals, and water and can be used in products such as medical devices, eyeglasses, and toys.
Some of the major players in the pharmaceutical polyacrylic resin market are Huzhou Zhanwang Pharmaceutical, Xi'an Yuelai Yiyao, Anhui Shanhe Pharmaceutical Excipients, Yuekang Yaoye Anhui Tianran Zhiyao, Lianyungang Wantai Pharmaceutical Material, Xi'an Tianzheng Medical Materials Co.,Ltd, Evonik, Huzhou Zhanwang Pharmaceutical.
The pharmaceutical polyacrylic resin market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pharmaceutical Polyacrylic resin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pharmaceutical Polyacrylic resin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pharmaceutical Polyacrylic resin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pharmaceutical Polyacrylic resin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pharmaceutical Polyacrylic resin Market Size & Forecast, 2018-2028
4.5.1 Pharmaceutical Polyacrylic resin Market Size and Y-o-Y Growth
4.5.2 Pharmaceutical Polyacrylic resin Market Absolute $ Opportunity
Chapter 5 Global Pharmaceutical Polyacrylic resin Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pharmaceutical Polyacrylic resin Market Size Forecast by Type
5.2.1 Polyacrylic resin III
5.2.2 Polyacrylic resin II
5.2.3 Polyacrylic resin IV
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pharmaceutical Polyacrylic resin Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pharmaceutical Polyacrylic resin Market Size Forecast by Applications
6.2.1 Tablet
6.2.2 Pill
6.2.3 Granules
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pharmaceutical Polyacrylic resin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pharmaceutical Polyacrylic resin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pharmaceutical Polyacrylic resin Analysis and Forecast
9.1 Introduction
9.2 North America Pharmaceutical Polyacrylic resin Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pharmaceutical Polyacrylic resin Market Size Forecast by Type
9.6.1 Polyacrylic resin III
9.6.2 Polyacrylic resin II
9.6.3 Polyacrylic resin IV
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pharmaceutical Polyacrylic resin Market Size Forecast by Applications
9.10.1 Tablet
9.10.2 Pill
9.10.3 Granules
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pharmaceutical Polyacrylic resin Analysis and Forecast
10.1 Introduction
10.2 Europe Pharmaceutical Polyacrylic resin Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pharmaceutical Polyacrylic resin Market Size Forecast by Type
10.6.1 Polyacrylic resin III
10.6.2 Polyacrylic resin II
10.6.3 Polyacrylic resin IV
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pharmaceutical Polyacrylic resin Market Size Forecast by Applications
10.10.1 Tablet
10.10.2 Pill
10.10.3 Granules
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pharmaceutical Polyacrylic resin Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pharmaceutical Polyacrylic resin Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pharmaceutical Polyacrylic resin Market Size Forecast by Type
11.6.1 Polyacrylic resin III
11.6.2 Polyacrylic resin II
11.6.3 Polyacrylic resin IV
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pharmaceutical Polyacrylic resin Market Size Forecast by Applications
11.10.1 Tablet
11.10.2 Pill
11.10.3 Granules
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pharmaceutical Polyacrylic resin Analysis and Forecast
12.1 Introduction
12.2 Latin America Pharmaceutical Polyacrylic resin Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pharmaceutical Polyacrylic resin Market Size Forecast by Type
12.6.1 Polyacrylic resin III
12.6.2 Polyacrylic resin II
12.6.3 Polyacrylic resin IV
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pharmaceutical Polyacrylic resin Market Size Forecast by Applications
12.10.1 Tablet
12.10.2 Pill
12.10.3 Granules
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pharmaceutical Polyacrylic resin Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pharmaceutical Polyacrylic resin Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pharmaceutical Polyacrylic resin Market Size Forecast by Type
13.6.1 Polyacrylic resin III
13.6.2 Polyacrylic resin II
13.6.3 Polyacrylic resin IV
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pharmaceutical Polyacrylic resin Market Size Forecast by Applications
13.10.1 Tablet
13.10.2 Pill
13.10.3 Granules
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pharmaceutical Polyacrylic resin Market: Competitive Dashboard
14.2 Global Pharmaceutical Polyacrylic resin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Huzhou Zhanwang Pharmaceutical
14.3.2 Xi'an Yuelai Yiyao
14.3.3 Anhui Shanhe Pharmaceutical Excipients
14.3.4 Yuekang Yaoye Anhui Tianran Zhiyao
14.3.5 Lianyungang Wantai Pharmaceutical Material
14.3.6 Xi'an Tianzheng Medical Materials Co.,Ltd
14.3.7 Evonik
14.3.8 Huzhou Zhanwang Pharmaceutical
